LUPINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.906
AS - Asia 1.722
EU - Europa 1.508
SA - Sud America 232
AF - Africa 26
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.399
Nazione #
US - Stati Uniti d'America 3.822
SG - Singapore 722
CN - Cina 504
IT - Italia 325
DE - Germania 288
PL - Polonia 270
BR - Brasile 199
FI - Finlandia 151
HK - Hong Kong 148
GB - Regno Unito 126
TR - Turchia 125
UA - Ucraina 97
VN - Vietnam 86
SE - Svezia 63
CA - Canada 41
ID - Indonesia 40
RU - Federazione Russa 39
MX - Messico 35
BE - Belgio 30
IN - India 23
NL - Olanda 20
RO - Romania 17
AT - Austria 16
CZ - Repubblica Ceca 16
FR - Francia 16
ZA - Sudafrica 16
AR - Argentina 13
BD - Bangladesh 13
JP - Giappone 11
ES - Italia 9
LT - Lituania 9
IQ - Iraq 8
IR - Iran 7
EC - Ecuador 6
IE - Irlanda 6
KZ - Kazakistan 5
CL - Cile 4
PE - Perù 4
AU - Australia 3
CO - Colombia 3
DZ - Algeria 3
PK - Pakistan 3
SA - Arabia Saudita 3
TW - Taiwan 3
UZ - Uzbekistan 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
JO - Giordania 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MQ - Martinica 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.399
Città #
Ashburn 451
Fairfield 430
Singapore 383
Woodbridge 349
Warsaw 268
Houston 226
Ann Arbor 222
Chandler 203
Beijing 201
Seattle 177
Munich 171
Santa Clara 170
Hong Kong 148
Cambridge 135
Wilmington 128
Jacksonville 125
Ferrara 113
Dallas 103
New York 99
Helsinki 75
Izmir 66
Los Angeles 65
Turku 47
Milan 46
Nanjing 45
Shanghai 42
Princeton 37
Jakarta 36
Brussels 30
San Diego 27
Ho Chi Minh City 26
Mexico City 25
London 24
Boardman 23
Nanchang 21
Chicago 20
Bremen 19
Buffalo 19
São Paulo 19
Tianjin 19
Addison 17
Phoenix 17
Timisoara 17
Denver 16
Falls Church 16
Hanoi 15
Brooklyn 14
Johannesburg 14
Orem 14
Rome 14
Brno 13
Dong Ket 13
Shenyang 13
Toronto 13
Changsha 12
Montreal 12
The Dalles 12
Atlanta 11
Nuremberg 11
Stockholm 11
Tokyo 11
Bologna 10
Boston 10
Poplar 10
Redwood City 10
Dearborn 9
Hebei 9
Amsterdam 8
Chennai 8
Columbus 8
Kunming 8
Manchester 8
Moscow 8
Rio de Janeiro 8
San Francisco 8
Council Bluffs 7
Frankfurt am Main 7
Washington 7
Auburn Hills 6
Dublin 6
Falkenstein 6
Hefei 6
Jiaxing 6
Mountain View 6
Salt Lake City 6
Vienna 6
Ankara 5
Brasília 5
Ferrara di Monte Baldo 5
Guarulhos 5
Haiphong 5
Naples 5
Ningbo 5
Philadelphia 5
Tampa 5
Belo Horizonte 4
Cagliari 4
Des Moines 4
Guangzhou 4
Hangzhou 4
Totale 5.375
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 277
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 266
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 261
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 252
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 249
Ruolo del miR-221 nella tumorigenesi epatica 239
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 234
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 225
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 220
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 219
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 214
Circulating non-coding RNA as biomarkers in colorectal cancer 209
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 207
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 206
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 205
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 202
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 188
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 187
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 183
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 182
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 180
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 179
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 172
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 168
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 163
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 161
Oncogenic role of miR-483-3p at the IGF2/483 locus 149
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 147
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 141
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 139
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 137
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 135
Mutated beta-catenin evades a microRNA-dependent regulatory loop 131
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 130
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 130
The importance of microRNAs in RAS oncogenic activation in human cancer 126
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 117
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 90
null 89
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 89
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 83
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 81
null 77
null 63
Totale 7.502
Categoria #
all - tutte 34.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.505
Totale 36.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021505 0 0 0 0 0 80 33 66 24 147 87 68
2021/2022451 23 30 30 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/20251.520 35 35 95 78 147 171 93 69 309 114 183 191
2025/20261.817 389 135 267 394 502 130 0 0 0 0 0 0
Totale 7.502